Related Experiment Video
Updated: May 5, 2026
10:19
Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
Published on: November 10, 2014
25.6K
Internist's tumour into thyroid: A case report
Pallab Kumar Sarkar1, Eranga Nissanka-Jayasuria2, Muhammad Eraibey3
1Department of Urology, East Kent Hospitals University NHS Foundation Trust, Canterbury, United Kingdom.
Journal of the West African College of Surgeons
|July 11, 2024
Summary
Metastatic renal cell carcinoma (RCC) can spread to unusual sites like the thyroid gland, even years after treatment. Early diagnosis requires a high suspicion in patients with a history of RCC.
Area of Science:
- Oncology
- Endocrinology
- Pathology
Background:
- Renal cell carcinoma (RCC) is recognized for its unpredictable behavior and propensity for metastasis.
- The thyroid gland is an uncommon site for metastasis, yet metastatic RCC is a frequent secondary thyroid malignancy.
Observation:
- This case report details a secondary thyroid neoplasm originating from renal cell carcinoma (RCC).
- The metastasis occurred 13 years after the patient underwent a radical nephrectomy for primary RCC.
- Diagnosis was established through a combination of high clinical suspicion, cross-sectional imaging, and biopsy.
Findings:
- The study describes the clinicopathological features of a rare case of thyroid metastasis from RCC.
- It highlights the potential for late recurrence and metastasis of RCC to unusual sites.
Implications:
- This case underscores the importance of considering metastatic RCC in the differential diagnosis of thyroid nodules, especially in patients with a history of kidney cancer.
- It emphasizes the need for a high index of suspicion and thorough diagnostic workup for suspected secondary thyroid malignancies.
- The findings contribute to the understanding of RCC's metastatic potential and the management of rare presentations.
Related Concept Videos
01:23The Thyroid Gland
7.0K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
7.0K
01:25Hyperthyroidism I: Introduction
59
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
59
01:27Hyperthyroidism II: Pathophysiology
36
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
36
01:28Graves' Disease I: Introduction
49
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
49
01:24Graves Disease II: Pathophysiology
33
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
33
01:27Goiter
40
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
40